C. Nolte et al., GFAP promoter-controlled EGFP-expressing transgenic mice: A tool to visualize astrocytes and astrogliosis in living brain tissue, GLIA, 33(1), 2001, pp. 72-86
We have generated transgenic mice in which astrocytes are labeled by the en
hanced green fluorescent protein (EGFP) under the control of the human glia
l fibrillary acidic protein (GFAP) promoter. In all regions of the CNS, suc
h as cortex, cerebellum, striatum, corpus callosum, hippocampus, retina, an
d spinal cord, EGFP-positive cells with morphological properties of astrocy
tes could be readily visualized by direct fluorescence microscopy in living
brain slices or whole mounts. Also in the PNS, nonmyelinating Schwann cell
s from the sciatic nerve could be identified by their bright green fluoresc
ence. Highest EGFP expression was found in the cerebellum. Already in acute
ly prepared whole brain, the cerebellum appeared green-yellowish under norm
al daylight. Colabeling with GFAP antibodies revealed an overlap with EGFP
in the majority of cells. Some brain areas, however, such as retina or hypo
thalamus, showed only low levels of EGFP expression, although the astrocyte
s were rich in GFAP. In contrast, some areas that were poor in immunoreacti
ve GFAP were conspicuous for their EGFP expression. Applying the patch clam
p technique in brain slices, EGFP-positive cells exhibited two types of mem
brane properties, a passive membrane conductance as described for astrocyte
s and voltage-gated channels as described for glial precursor cells. Electr
on microscopical investigation of ultrastructural properties revealed EGFP-
positive cells enwrapping synapses by their fine membrane processes. EGFP-p
ositive cells were negative for oligodendrocyte (MAG) and neuronal markers
(NeuN). As response to injury, i.e., by cortical stab wounds, enhanced leve
ls of EGFP expression delineated the lesion site and could thus be used as
a live marker for pathology. GLIA 33:72-86, 2001. (C) 2001 Wiley-Liss, Inc.